New Times,
New Thinking.

  1. Business
  2. Economics
8 March 2012

Balls backs a mansion tax

Shadow chancellor offers qualified support for new tax.

By George Eaton

Ed Balls has used an interview with the BBC’s Nick Robinson to offer his (qualified) support for a mansion tax. “If the Chancellor wants to go down that road then I will support him,” he said.

However, he reiterated that Labour did not want to see it introduced as a direct replacement for the 50p tax rate. The purpose of a mansion tax should be “to help families facing higher tuition fees, higher VAT or higher fuel bills,” he argued.

Intriguingly, he also echoed the concerns of some on the right, declaring that “you can’t have people being thrown out of their homes because they can’t afford to pay the tax”.

It’s a point we rebut in our leader this week, which calls for the burden of taxation to be shifted from income to wealth.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Opponents of a mansion tax complain that it would penalise the equity-rich but income-poor and force some pensioners to sell their family homes. Yet this is little more than sentimentalism and special pleading. There is no good reason for the elderly to occupy valuable houses that are far too large for them and that they cannot afford to maintain.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines